Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Cancer Epidemiol Biomarkers Prev
    April 2024
  1. WANG J, Wang Q, Shi Z, Yan X, et al
    Serum lipid levels, genetic risk, and lung cancer incidence: A large prospective cohort study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  2. ALLAIRE BT, Horvath ML, Lines LM, Davidoff AJ, et al
    Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a Decade of SEER Medicare Health Outcomes Survey Data.
    Cancer Epidemiol Biomarkers Prev. 2024;33:593-599.
    >> Share

    February 2024
  3. BOOKSTEIN A, Po J, Tseng C, Larson TV, et al
    Association between Airport Ultrafine Particles and Lung Cancer Risk: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  4. PELLAND-ST-PIERRE L, Pham MC, Nguyen AQH, Pasquet R, et al
    The Influence of Smoking and Occupational Risk Factors on DNA Methylation in the AHRR and F2RL3 Genes.
    Cancer Epidemiol Biomarkers Prev. 2024;33:224-233.
    >> Share

  5. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    >> Share

    January 2024
  6. YOON HS, Wu J, Shidal C, Sun Y, et al
    Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  7. LIU Q, Medina HN, Rodriguez E, Jacobs KT, et al
    Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  8. DUNCAN MS, Diaz-Zabala H, Jaworski J, Tindle HA, et al
    INTERACTION BETWEEN CONTINUOUS PACK-YEARS SMOKED AND POLYGENIC RISK SCORE ON LUNG CANCER RISK: PROSPECTIVE RESULTS FROM THE FRAMINGHAM HEART STUDY.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  9. GRABSKI IN, Heymach JV, Kehl KL, Kopetz S, et al
    Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum.
    Cancer Epidemiol Biomarkers Prev. 2024;33:158-169.
    >> Share

  10. LI Y, Xiao X, Li J, Han Y, et al
    Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.
    Cancer Epidemiol Biomarkers Prev. 2024 Jan 5. doi: 10.1158/1055-9965.EPI-23-0613
    >> Share

    November 2023
  11. YANG Z, He H, He G, Zeng C, et al
    Investigating Causal Effects of Hematological Traits on Lung Cancer: A Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 1. doi: 10.1158/1055-9965.EPI-23-0725
    >> Share

    September 2023
  12. WONG JY, Shu XO, Hu W, Blechter B, et al
    Associations between longer leukocyte telomere length and increased lung cancer risk among never smokers in urban China.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

    August 2023
  13. TRENDOWSKI MR, Lusk CM, Wenzlaff AS, Neslund-Dudas C, et al
    Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 14:EPI-23-0174.
    >> Share

  14. PETTIT RW, Byun J, Han Y, Ostrom QT, et al
    Heritable Traits and Lung Cancer Risk: A Two-Sample Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 2:EPI-22-0698.
    >> Share

    July 2023
  15. SEDETA E, Sung H, Laversanne M, Bray F, et al
    Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide.
    Cancer Epidemiol Biomarkers Prev. 2023;32:894-905.
    >> Share

    June 2023
  16. SALVATORE M, Hu MM, Beesley LJ, Mondul AM, et al
    COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination.
    Cancer Epidemiol Biomarkers Prev. 2023;32:748-759.
    >> Share

    May 2023
  17. SHARIFIAN N, Carey FR, Seay JS, Castaneda SF, et al
    Risk and Protective Factors for Cancer Mortality among United States Service Members and Veterans (2001-2018).
    Cancer Epidemiol Biomarkers Prev. 2023;32:606-616.
    >> Share

  18. LUO R, Zhong P, Li X, Cai J, et al
    High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2023;32:726-738.
    >> Share

    April 2023
  19. LI FX, Zhao HY, Lin TF, Jiang YW, et al
    Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort.
    Cancer Epidemiol Biomarkers Prev. 2023;32:531-541.
    >> Share

    March 2023
  20. ETEMADI A, Abnet CC, Dawsey SM, Freedman ND, et al
    Biomarkers of Tobacco Carcinogenesis in Diverse Populations: Challenges and Opportunities.
    Cancer Epidemiol Biomarkers Prev. 2023;32:289-291.
    >> Share

    December 2022
  21. CHANDRAN U, Reps J, Yang R, Vachani A, et al
    Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 28:EPI-22-0873.
    >> Share

  22. MARMOR HN, Deppen SA, Welty V, Kammer MN, et al
    Improving Lung Cancer Diagnosis with Computed Tomography Radiomics and Serum Histoplasmosis Testing.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 16:EPI-22-0532.
    >> Share

  23. RUEL LJ, Li Z, Gaudreault N, Henry C, et al
    Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2219-2227.
    >> Share

    November 2022
  24. SHREVES AH, Buller ID, Chase E, Creutzfeldt H, et al
    Geographic Patterns in U.S. Lung Cancer Mortality and Cigarette Smoking.
    Cancer Epidemiol Biomarkers Prev. 2022 Nov 22:EPI-22-0253.
    >> Share

  25. CIGAN SS, Murphy SE, Stram DO, Hecht SS, et al
    Association of urinary biomarkers of smoking-related toxicants with lung cancer incidence in smokers: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Nov 9. pii: 710531.
    >> Share

    September 2022
  26. CHIEN LH, Chen TY, Chen CH, Chen KY, et al
    Recalibrating risk prediction models by synthesizing data sources: adapting the lung cancer PLCO model for Taiwan.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 21. pii: 709337.
    >> Share

  27. FORTUNATO O, Huber V, Segale M, Cova A, et al
    Development of a molecular blood-based immune signature classifier as biomarker for risks assessment in Lung Cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 16. pii: 708821.
    >> Share

  28. SHOME M, Gao W, Engelbrektson A, Song L, et al
    Comparative microbiomics analysis of anti-microbial antibody response between lung cancer patients and control subjects with benign pulmonary nodules.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 3. pii: 709014.
    >> Share

    August 2022
  29. ZHOU B, Lu J, Beck JD, Moss KL, et al
    Periodontal and other oral bacteria and risk of lung cancer in the Atherosclerosis Risk in Communities (ARIC) Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 23. pii: 708566.
    >> Share

  30. BEABER EF, Kamineni A, Burnett-Hartman AN, Hixon B, et al
    Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1521-1531.
    >> Share

    July 2022
  31. SMITH-BYRNE K, Cerani A, Guida F, Zhou S, et al
    Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Pre-Diagnostic Blood Measurements.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 15. pii: 707037.
    >> Share

    June 2022
  32. BACKENROTH D, Snider J, Shen R, Seshan V, et al
    Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1195-1201.
    >> Share

    May 2022
  33. DU Y, Sidorenkov G, Groen HJ, Heuvelmans MA, et al
    Airflow limitation increases lung cancer risk in smokers: the Lifelines cohort study.
    Cancer Epidemiol Biomarkers Prev. 2022 May 9. pii: 696484.
    >> Share

    April 2022
  34. MUKHERJEE S, Bandlamudi C, Hellmann MD, Kemel Y, et al
    Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 27. pii: 694787.
    >> Share

  35. OLSSON A, Guha N, Bouaoun L, Kromhout H, et al
    Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: results from a pooled analysis of case-control studies (SYNERGY).
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 18. pii: 694483.
    >> Share

  36. HUNG RJ
    Biomarker-Based Lung Cancer Screening Eligibility: Implementation Considerations.
    Cancer Epidemiol Biomarkers Prev. 2022;31:698-701.
    >> Share

    January 2022
  37. PEERI NC, Tao MH, Demissie S, Nguyen UD, et al
    Sleep duration, chronotype, and insomnia and the risk of lung cancer: United Kingdom Biobank Cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 27. pii: 1055-9965.EPI-21-1093.
    >> Share

  38. JACOBSEN KK, Schnohr P, Jensen GB, Bojesen SE, et al
    AHRR (cg5575921) methylation safely improves specificity of lung cancer screening eligibility criteria: A cohort study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-1059.
    >> Share

  39. SCHMID S, Jiang M, Brown MC, Fares A, et al
    Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 13. pii: 1055-9965.EPI-21-0747.
    >> Share

    December 2021
  40. INOUE K, Hsu W, Arah OA, Prosper AE, et al
    Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2227-2234.
    >> Share

    November 2021
  41. YUAN Q, Du M, Loehrer E, Johnson BE, et al
    Post-diagnosis BMI change is associated with non-small cell lung cancer survival.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 2. pii: 1055-9965.EPI-21-0503.
    >> Share

    September 2021
  42. GHOSH T, Chen Y, Dietz AC, Armstrong GT, et al
    Lung Cancer as a Subsequent Malignant Neoplasm in Survivors of Childhood Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 14. pii: 1055-9965.EPI-21-0250.
    >> Share

    August 2021
  43. FAN Y, Su Z, Wei M, Liang H, et al
    Long-term lung cancer risk associated with sputum atypia: a 27-year follow-up study of an occupational lung screening cohort in Yunnan, China.
    Cancer Epidemiol Biomarkers Prev. 2021 Aug 26. pii: 1055-9965.EPI-21-0339.
    >> Share

    June 2021
  44. ABE SK, Narita S, Saito E, Sawada N, et al
    Body mass index, height, weight change, and subsequent lung cancer risk: the Japan Public Health Center-based Prospective Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 25. pii: 1055-9965.EPI-21-0195.
    >> Share

  45. WOOD AM, Jonsson H, Nagel G, Haggstrom C, et al
    The inverse association of body mass index with lung cancer: exploring residual confounding, metabolic aberrations and within-person variability in smoking.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 22. pii: 1055-9965.EPI-21-0058.
    >> Share

  46. ZHANG EW, Shepard JO, Kuo A, Chintanapakdee W, et al
    Characteristics and outcomes of lung cancers detected on low-dose lung cancer screening CT.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 9. pii: 1055-9965.EPI-20-1847.
    >> Share

  47. ERHUNMWUNSEE L, Wing SE, Shen J, Hu H, et al
    The Association between Polluted Neighborhoods and TP53-Mutated Non-Small Cell Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 4. pii: 1055-9965.EPI-20-1555.
    >> Share

    May 2021
  48. DEROUEN MC, Thompson CA, Canchola AJ, Jin A, et al
    Integrating electronic health record, cancer registry, and geospatial data to study lung cancer in Asian American, Native Hawaiian and Pacific Islander ethnic groups.
    Cancer Epidemiol Biomarkers Prev. 2021 May 17. pii: 1055-9965.EPI-21-0019.
    >> Share

    April 2021
  49. WILUNDA C, Sawada N, Yamaji T, Iwasaki M, et al
    Reproductive factors and lung cancer risk among never-smoking Japanese women with 21 years of follow-up: a cohort study.
    Cancer Epidemiol Biomarkers Prev. 2021 Apr 7. pii: 1055-9965.EPI-20-1399.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016